NDC 82260-734

NDC codes

FDA NDC Directory

Product NDC (as listed)82260-734Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82260-0734Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82260-734-05	82260073405	1 BOTTLE, GLASS in 1 CARTON (82260-734-05) / 5 mL in 1 BOTTLE, GLASSMarketed from Mar 20, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluorescein Sodium and Benoxinate Hydrochloride
Generic name (nonproprietary): fluorescein sodium and benoxinate hydrochloride
Active ingredients: Fluorescein sodium — 2.6 mg/mLBenoxinate hydrochloride — 4.4 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Bausch & Lomb Americas Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 211039
Marketing start: Mar 20, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Dyes (Mechanism)
Identifiers: Product ID 82260-734_34f4e654-be4a-0c13-e063-6394a90a629dSPL ID 34f4e654-be4a-0c13-e063-6394a90a629dSPL set ID f935b5f8-dc6e-4425-a668-968ee3855f51RxCUI 2287005UNII 93X55PE38X, 0VE4U49K15
Pharmacologic class: Diagnostic Dye

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482260073405 followed by a unit qualifier and the quantity

Package 82260-0734-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 12, 2025.

Indications (excerpt from the label)

Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is a combination of fluorescein sodium, a disclosing agent and benoxinate hydrochloride, a local ester anesthetic indicated for procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 211039

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 211039
Product	Strength	Form · route	Labeler	Product NDC
Fluorescein Sodium and Benoxinate Hydrochloride	Fluorescein sodium 2.6 mg/mL; Benoxinate hydrochloride 4.4 mg/mL	Solution/ dropsOphthalmic	Bausch & Lomb Incorporated	24208-734

Fluorescein Sodium and Benoxinate Hydrochloride NDC 82260-734